News

The topping out of the Moffitt Discovery & Innovation Center for research and the installation of a cyclotron are the first ...
Some cancers remain stubbornly difficult to diagnose at early stages. Pancreatic, ovarian, lung, liver and kidney cancers ...
You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge ...
Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) ...
Monitoring and analyzing gut microbes may help predict how myeloma patients will respond to CAR T-cell therapy, research ...
Cancer care can vary significantly from hospital to hospital, especially for patients considering clinical trials.  The quest ...
TAMPA, Fla. — At Tampa’s Moffitt Cancer Center, the Arts in Medicine program is providing a different kind of healing to the patients. Cancer patient Everett Paul Cole found out what makes ...
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that ...
Executive leadership changes with Dr. Paul Stoffels retiring as CEO upon appointment of his successor while continuing as Chair of the Board, Thad Huston departing as CFO/COO on August 1, 2025, and ...
The cohort of 12 helped shape the new program, which was launched four years ago to address the state's critical nursing ...
Hany Elmariah, MD, discusses how he sees fedratinib fitting into clincal practice for the treatment of myeloproliferative neoplasms.